Nygen Analytics AB

Nygen Analytics AB is a Swedish software company based in Lund that builds an AI-native interpretation layer for single-cell omics data. Its product stack is aimed at research institutions, consortia, and translational programs that generate single-cell RNA-seq and related datasets and need to turn clusters of cells into defensible, ontology-anchored biological calls. The company positions itself around the idea of decoding every cell: surfacing deeper signal, faster clarity, and better decisions than conventional analysis workflows. The core of the offering is CyteType, an AI-powered cell type annotation product. CyteType deploys specialized AI reviewers that annotate each cluster with ontology-mapped labels, marker-level evidence, functional state resolution, and confidence-scored quality control. Its outputs include supporting, missing, and unexpected marker evidence, functional state descriptions, and reviewer synthesis, so that annotations can be traced, audited, and acted upon. Nygen markets CyteType for consortium-scale cell atlas annotation, cell therapy programs, immuno-oncology studies, translational safety and toxicology, biomarker and responder stratification, and clinical immune monitoring. A second product, ScarfWeb, is a browser-based analysis layer for single-cell omics. It lets researchers explore clusters, run marker analysis, annotate cell types, and share reproducible findings without writing code or provisioning compute. CyteType runs directly inside a ScarfWeb analysis session, so annotation, confidence scoring, marker-level evidence, ontology mapping, and literature linking happen in the same workspace. ScarfWeb supports data upload or connection to curated datasets, publication-ready outputs, real-time collaboration, public or private sharing, and export for scripted pipelines. Nygen describes its technology as powering discovery at leading research institutions and states that its tools are used by more than 1,500 researchers across over 100 top global institutions, with more than 100,000 clusters annotated at a 99.99% completion rate. The company also references ISO 27001 and SOC 2 readiness for ScarfWeb. Nygen Analytics AB is a private company; no parent, owner, or listed status is indicated in the available evidence.

Nygen Analytics AB is a company based in Lund, Sweden, according to its Wikidata entry. Public evidence available here does not specify a founding date, founders, or funding history. What is documented is the company's product direction: it has built an AI-native interpretation layer for single-cell omics, marketed under the Nygen brand and delivered through a focused product stack. The company's flagship product, CyteType, is an AI-powered cell type annotation tool. CyteType assigns cell identity using structured AI reasoning, deploying specialized AI reviewers that annotate each cluster with ontology-mapped labels, marker-level evidence, functional state resolution, and confidence-scored quality control. Its outputs are designed to be traceable and auditable, with marker evidence reported as supporting, missing, or unexpected, and with functional state descriptions such as activated lipid-secretory states. Nygen reports that CyteType has annotated more than 100,000 clusters at a 99.99% completion rate, and it markets the product for consortium-scale cell atlas annotation, cell therapy programs, immuno-oncology studies, translational safety and toxicology, biomarker and responder stratification, and clinical immune monitoring. A second product, ScarfWeb, extends the platform into browser-based analysis. ScarfWeb is a no-code, full-stack single-cell analysis environment covering steps from quality control to differential expression, with adjustable parameters, versioned and auditable workflows, and real-time collaboration. CyteType runs directly inside a ScarfWeb analysis session, so annotation, confidence scoring, marker-level evidence, ontology mapping, and literature linking are available without exporting to a separate tool. ScarfWeb supports uploading data or connecting to curated datasets, sharing results via public links or private access, publishing to the Nygen Database, and exporting for scripted pipelines. Nygen states that ScarfWeb is used by more than 1,500 researchers across over 100 top global institutions and that it is ISO 27001 and SOC 2 ready. Nygen positions its technology as powering discovery at the world's leading research institutions and describes its mission as pushing single-cell programs past description into discovery. The company is private, and the available evidence does not identify a parent company, owner, or listing.

AI-native interpretation layer for single-cell omics, delivering traceable, ontology-anchored, confidence-scored cell annotations at production scale.

• CyteType

  AI-powered cell type annotation product that deploys specialized AI reviewers to annotate each cluster with ontology-mapped labels, marker-level evidence, functional state resolution, and confidence-scored quality control. Reports 100,000+ clusters annotated at a 99.99% completion rate.

• ScarfWeb

  Browser-based, no-code single-cell analysis layer covering QC to differential expression, with CyteType embedded, real-time collaboration, public or private sharing, and export for scripted pipelines. Stated to be used by 1,500+ researchers at 100+ top global institutions and ISO 27001 + SOC 2 ready.

• Nygen Database

  A destination referenced in ScarfWeb for publishing results.

1. 1Nygen | AI Platform for Single-Cell Discoverynygen.io
2. 2CyteType | AI-Powered Cell Type Annotationnygen.io
3. 3ScarfWeb | Browser-Based Single-Cell Analysisnygen.io
4. 4Nygen Analytics AB (Sweden) - Wikidatawikidata.org